会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 경피투여용 항구토제 조성물 및 이를 포함하는 제제
    • 用于超导管理的抗微生物组合物及其制备方法
    • KR1020010014479A
    • 2001-02-26
    • KR1020000006059
    • 2000-02-09
    • 주식회사 삼양홀딩스
    • 서보연황준석조중웅최영권
    • A61K31/40
    • PURPOSE: An antiemetic composition for transdermal administration and preparations containing the composition are provided to treat or prevent emesis resulted from a radiotherapy, the use of anticancer agents and a surgical operation, to maintain the effective concentration of a drug in blood by slow permeation of an antiemetic component for at least 24 hours, and to have no side effects. CONSTITUTION: An antiemetic composition comprises a base for transdermal administration containing: (1) 20-80% by weight of hydrophilic organic solvent, (2) 1-5% by weight of a skin-permeation promoter selected from a group consisted of fatty acid or derivatives thereof, fatty acid alcohol or derivatives thereof, amide compounds, terphen compounds, surfactant and mixtures thereof, and (3) 15-80% by weight of water; and 1-15% by weight of antiemetic components selected from a group consisting of tropisetron, ondansetrone and granisetrone based on 100% by weight of the base. Preferably, the preparations are provided in the patch form.
    • 目的:提供用于透皮给药的止吐组合物和含有该组合物的制剂,用于治疗或预防放射治疗引起的呕吐,使用抗癌剂和外科手术,通过缓慢渗透血液来维持药物在血液中的有效浓度 止吐成分至少24小时,无副作用。 构成:止吐组合物包含用于透皮给药的基质,其包含:(1)20-80重量%的亲水性有机溶剂,(2)1-5重量%的皮肤渗透促进剂,其选自脂肪酸 或其衍生物,脂肪酸醇或其衍生物,酰胺化合物,三烯化合物,表面活性剂及其混合物,和(3)15-80重量%的水; 和1-15重量%的选自托酯,四聚体和格兰四酮的基于100重量%的碱的止吐成分。 优选地,制剂以贴片形式提供。
    • 2. 发明授权
    • 발기부전치료용약물조성및경피투여제형
    • 用于勃起功能障碍治疗的药物制剂和透皮剂型
    • KR100287626B1
    • 2001-04-16
    • KR1019950043422
    • 1995-11-24
    • 주식회사 삼양홀딩스
    • 이헌한조중웅백재승
    • A61K9/70A61K31/557
    • PURPOSE: A patch composition for treatment of erectile impotence comprising prostaglandin E1, a stabilizer and a penetration enhancer is provided. Also provided is a patch device comprising a patch composition-containing patch, a supporter for supporting the patch and a compression ring. The patch device helps treat erectile dysfunction and stimulates erection effectively. CONSTITUTION: The patch composition comprises 5 to 30% by weight of an erection-inducing composition such as prostaglandin E1, minoxidil or linsidomine, 1 to 60% by weight of one or more stabilizers such as polyethylene glycol, triacetin, propylene glycol or ethanol and 1 to 50% by weight of one or more skin penetration enhancers selected from cetyl alcohol, stearyl alcohol, 1-dodecanol, oleyl alcohol, lactic acid, oleic acid, salicylic acid, lecithin, linoleic acid, linolenic acid, bile salt, monoolein, 1-menthol or ethanol. The patch device comprises a patch(20) containing the patch composition, a band type supporter and a ring(30) for compressing the base part of the genitals, wherein the patch comprises a backing layer, a matrix or a drug layer, a porous membrane and a removable film.
    • 5. 发明授权
    • 경피투여용 항구토제 조성물 및 이를 포함하는 제제
    • 경피투여용항구토제조성물및이를포함하는제제
    • KR100390870B1
    • 2003-07-10
    • KR1020000006059
    • 2000-02-09
    • 주식회사 삼양홀딩스
    • 서보연황준석조중웅최영권
    • A61K31/40
    • PURPOSE: An antiemetic composition for transdermal administration and preparations containing the composition are provided to treat or prevent emesis resulted from a radiotherapy, the use of anticancer agents and a surgical operation, to maintain the effective concentration of a drug in blood by slow permeation of an antiemetic component for at least 24 hours, and to have no side effects. CONSTITUTION: An antiemetic composition comprises a base for transdermal administration containing: (1) 20-80% by weight of hydrophilic organic solvent, (2) 1-5% by weight of a skin-permeation promoter selected from a group consisted of fatty acid or derivatives thereof, fatty acid alcohol or derivatives thereof, amide compounds, terphen compounds, surfactant and mixtures thereof, and (3) 15-80% by weight of water; and 1-15% by weight of antiemetic components selected from a group consisting of tropisetron, ondansetrone and granisetrone based on 100% by weight of the base. Preferably, the preparations are provided in the patch form.
    • 目的:提供一种用于经皮给药的止吐组合物和含有该组合物的制剂,用于治疗或预防由放射疗法,抗癌剂的使用和外科手术引起的呕吐,通过缓慢渗透的方式维持药物在血液中的有效浓度 止吐组分至少24小时,并且没有副作用。 组成:止吐组合物包含用于透皮给药的基质,其含有:(1)20-80%重量的亲水性有机溶剂,(2)1-5%重量的选自脂肪酸的皮肤渗透促进剂 或其衍生物,脂肪酸醇或其衍生物,酰胺化合物,terphen化合物,表面活性剂及其混合物,和(3)15-80重量%的水; 和基于100重量%的碱选自托烷司琼,昂丹司琼和格兰西酮的1-15重量%的止吐组分。 优选地,制剂以贴剂形式提供。
    • 7. 发明公开
    • 허브추출액을 이용한 니코틴의 자극완화용 약학 조성물
    • 使用草药提取物治疗非诺贝特激素的药物组合物
    • KR1020070066439A
    • 2007-06-27
    • KR1020050127611
    • 2005-12-22
    • 주식회사 삼양홀딩스
    • 이헌한조중웅
    • A61K36/53A61K31/465A61P25/34
    • A61K31/465A61K36/53A61K47/26A61K47/46Y10S514/813
    • A pharmaceutical composition comprising nicotine and an extract of herb is provided to be adapted for an anti-smoking aid by effectively masking an irritating taste of the nicotine through the use of the natural herb extract. The pharmaceutical composition for alleviating nicotine irritation comprises 0.01-5 wt.% of nicotine and 0.1-5 wt.% of an extract of herb which is at least one selected from the group consisting of lavender, rosemary, vervain, chamomile, thyme, sage, marshmallow, licorice root, lemon balm, Eucalyptus globulus, violet, blackberry, hyssop, stevia, asian plantain, scented geranium, borage family, Achillea Millefolium, Sambucus williamsii var. coreana, savory, greek sage, basil, angelica, orris, Japanese anise tree, mullein, mallow, chives, peppermint, and caraway. The composition further comprises a fruit concentrate or a sweetener.
    • 提供了包含尼古丁和草药提取物的药物组合物,以通过使用天然草本提取物有效地掩盖尼古丁的刺激性味道而适用于抗吸烟辅助剂。 用于缓解尼古丁刺激的药物组合物包含0.01-5重量%的尼古丁和0.1-5重量%的草药提取物,其为选自薰衣草,迷迭香,vervain,洋甘菊,百里香,圣人中的至少一种 ,棉花糖,甘草根,柠檬香草,桉树,紫罗兰,黑莓,海索草,甜叶菊,亚洲车前草,香草天竺葵,琉璃苣科,枸杞子, 木香,美味,希腊圣人,罗勒,当归,日本茴香树,马勒,马蹄,香葱,薄荷和香菜。 组合物还包含果实浓缩物或甜味剂。